|
MINUTES
2006-2010 Executive Committee Meeting
July 8th, 2006
Beijing International Convention Center
Room 13, 10:00 a.m.
Beijing, China
Participants:
Donald Birkett, Australia, Vice Chair of Clinical Pharmacology Division
Kim Brøsen, Denmark, Councilor
Patrick du Souich, Canada, Chair of Clinical Pharmacology Division
Sue Piper Duckles, USA, President
S. J. Enna, USA, Secretary-General
Mohamed Khayyal, Egypt, Councilor
Gabrielle Hawksworth, UK, Councilor
Salomon Langer, Israel, First Vice-President
Zhi-Bin Lin, China, Councilor
Masayoshi Mishina, Japan, Second Vice-President
Urs Ruegg, Switzerland, Treasurer
Petra Thürmann, Germany, Treasurer of Clinical Pharmacology Division
Paul Vanhoutte, Hong Kong, Past President
David Webb, UK, Representative of Clinical Pharmacology Division
Lindsay Hart, USA, Administrative Support
Lynn LeCount, USA, Administrative Support
Excused:
Sérgio Ferreira, Brazil, Councilor
Welcome and Opening Remarks:
President Sue Piper Duckles welcomed the new Executive Committee members and
encouraged all of them to contribute. She emphasized that coordination and
communication will be accomplished through e-mail and the IUPHAR website (www.iuphar.org).
Secretary-General S. J. Enna
commented that the prior Executive Committee had done an excellent job in
guiding the union. Finances had been challenging, so a primary task of this
Executive Committee will be to stabilize the funding to enable IUPHAR to broaden
its impact on the field. He recommended the use of specific projects or
initiatives as possible mechanisms for pursuing support.
2002 Executive Committee Recommendations:
The following recommendations
made from the 2002-2006 Executive Committee were considered by the 2006-2010
Executive Committee with the following outcomes:
- The need to enhance income – It was agreed to put
together one or two proposals using a specific project or initiative as the
mechanism for soliciting funds.
- Continuous improvement of accounting – It was agreed
to continue the practice of performing internal audits and external audits.
A bookkeeper has been retained to provide professional accounting services.
- The reappointment of Dr. Karl Netter as chair of the
Membership Committee – Dr. Netter’s reappointment was unanimously approved.
- The Spanish Society of Clinical Pharmacology may now
be notified of gaining full membership by virtue of the General Assembly’s
approval to modify the statutes. It was also observed that other clinical
pharmacology societies should be invited to join IUPHAR now that the
statutes allow more than one society per country to be a full member.
- The current associate members should be notified of
the change in statutes in the event any of them would care to apply for full
membership status.
- The appointment of Dr. Paul Vanhoutte as the Executive
Committee liaison to the newly approved Natural Products section – Dr.
Vanhoutte’s appointment was unanimously approved.
- The Pharmacology Society in Malta wishes to join
IUPHAR, but having fewer than 20 members this group fails to qualify for
membership status. It was agreed an effort should be made to find some way
to include this group in the organization without violating the existing
statutes. – The officers will take this under advisement and make a proposal
for discussion at the next EC meeting.
- The Teaching section has been developing well and is
now contributing materials to the IUPHAR website to assist educators around
the world. It is recommended that quality control and formal organization
of the material now be considered. – The Executive Committee suggested
inviting the chair of the Section to the officers’ meeting in November, 2006
to discuss strategies for implementing these enhancements.
- The appointment of Dr. Paul Vanhoutte as the Executive
Committee liaison to the International Council for Science (ICSU) – Dr.
Vanhoutte’s appointment was unanimously approved.
- The appointment of Dr. Mohamed Khayyal as the
Executive Committee liaison to the African Initiative sponsored by the South
African Society – Dr. Khayyal’s appointment was unanimously approved.
- The reappointment of Dr. Michael Spedding as the chair
of the IUPHAR Nomenclature Committee (NC-IUPHAR) – Dr. Spedding’s
reappointment was unanimously approved.
- The empowerment of the NC-IUPHAR officers to raise
funds – This was discussed and unanimously approved.
- Broaden the membership of the Executive Committee to
provide more clinical pharmacology division representation – Two
additional Executive Committee positions have been created to allow for
additional representation from the Clinical Pharmacology Division. Drs.
Petra Thürmann and David Webb will serve in these positions until 2010.
- Encourage the incoming Executive Committee to meet
annually and the Officers to meet biannually – The Executive Committee
endorsed these recommendations.
Budgetary Issues:
Per the procedures established
to transition between the Treasurers, Dr. Urs Ruegg is responsible for
transactions occurring on or after July 1st, 2006. The 2002-2006
Treasurer, Dr. Salomon Langer, will ensure the external audit of the 2005
finances is completed. After reconciling the June 2006 bank statement, Dr.
Langer will transfer the documents and transactions that have occurred January
1, 2006 through June 30, 2006 to Dr. Ruegg no later than August 1st,
2006.
The calendar year budget has
averaged around US$250,000 over the past few years. The need for transparency
for members and potential donors was emphasized. Ms. Laurence Barchietto, of
Ernst & Young Accounting, has been retained to serve as bookkeeper. According
to the statutes, Dr. Ruegg will prepare a one-year prospective budget to be
presented at the autumn officers meeting. He was also encouraged to consider
outlining the financial needs of the upcoming four years. The amount of desired
reserve was discussed and will be an agenda item for the spring Executive
Committee meeting. In the meantime, it was agreed to keep sufficient cash
available to meet ongoing obligations.
Membership:
Following the approval of Dr.
Netter’s reappointment as chair of the Membership Committee, the Executive
Committee further recommended that Drs. Huang Yu (Hong Kong), Collen
Masimirembwa (Zimbabwe), Regina Markus (Brazil) and Darrell Abernethy (USA) be
invited to serve as members of the committee.
The Pharmacology Society of
Malaysia has been dissolved and will, therefore, be removed from the roster of
IUPHAR members.
It was recommended that the
Mexican Association of Pharmacologists be approached about reactivating their
membership in IUPHAR.
IUPHAR Meetings:
An International Advisory Board
was established to provide guidance and feedback to the organizers of the 2008
World Conference of Clinical Pharmacology and Therapeutics to be held in
Quebec. Per IUPHAR statutes, Dr. Duckles will serve as chair of the committee.
The members include Drs. Stuart McCloud (Chair, 2010 Copenhagen Organizing
Committee), Donald Birkett (Chair, 2004 Brisbane Organizing Committee), David
Webb (Representative, Clinical Pharmacology Division), and Mohamed Khayyal
(Councilor, Executive Committee).
A Finance Committee was
established to negotiate the contract with the
Danish Society of
Pharmacology and Toxicology for the 16th World Congress on
Basic and Clinical Pharmacology 2010 (WorldPharma 2010) to be held in
Copenhagen. Per IUPHAR statutes, Dr. Ruegg will serve as chair of the
committee. The members include Drs. Duckles, Enna, Thürmann (Treasurer,
Clinical Pharmacology Division), Kim Brøsen (President, WorldPharma 2010),
Michael Mulvany (Secretary-General, WorldPharma 2010), and Ian Ahnfelt Rønne
(Representative, WorldPharma 2010). Dr. Ruegg will organize a meeting of this
group in conjunction with the spring 2007 NC-IUPHAR meeting.
Divisions and Sections:
The Clinical Pharmacology
Division requested up to $5,000 per year to cover administrative costs for four
years beginning in 2006 to assist them in developing the Division’s activities
for WorldPharma 2010. After discussion, the funding was unanimously approved.
Neuropsychopharmacology – It was
recommended that IUPHAR extend an invitation to the American College of
Neuropsychopharmacology (ACNP) to bolster activity in this section. Drs. Enna
and Langer will explore this possibility with ACNP.
Pharmacogenetics – It was
proposed, and unanimously approved, that this section becomes part of the
Clinical Pharmacology Division. It was recommended that Dr. Ingolf Cascorbi be
asked to serve as chair of the Pharmacogenetics Section to help re-invigorate
this unit.
Teaching – It was noted the
contributions of the Teaching section are particularly valuable in facilitating
IUPHAR’s mission to enhance pharmacology in developing countries. The idea of
creating modules was put forward, with the reminder that quality control and an
intuitive organization are essential for success. The Executive Committee will
encourage the chair to obtain feedback from countries that will benefit from the
material.
Natural Products – The
appointment of Dr. Ricky Man as chair of the newly approved Natural Products
section was unanimously approved. Additionally, the Executive Committee
encourages Dr. Man to consider Dr. Yong-Xiang Zhang, a nominee from Dr. Zhi-Bin
Lin, as a Vice or Co-chair for assistance. The Executive Committee also
formally approved the motion to include a liaison from the Clinical Pharmacology
Division to the Natural Products section.
NC-IUPHAR:
Dr. Duckles encouraged the
Executive Committee members to communicate nominees for possible NC-IUPHAR
members to Dr. Spedding.
In the past, the American
Society of Pharmacology and Experimental Therapeutics (ASPET) has published the
NC-IUPHAR review articles in Pharmacological Reviews. This contract
automatically renews in November of 2006, although either party may terminate
the agreement with six months notification. It was agreed this issue will be
discussed further at the NC IUPHAR meeting in November, 2006.
Representatives to International Organizations:
The following liaisons were
approved by the Executive Committee.
ICSU – Dr. Paul Vanhoutte (Hong Kong)
WHO – Dr. Folke Sjoqvist (Sweden)
ICLAS – Dr. Joseph Haywood (USA)
ICMAP – Dr. Ricky Man (Hong Kong)
IUPS – Dr. Salomon Langer (Israel)
IUTOX – Dr. Gabrielle Hawksworth (UK)
IFCS – Dr. Gabrielle Hawksworth (UK)
CODATA – Dr. Rick Neubig (USA)
IUPAC – Dr. Michael Spedding (UK)
African Initiative – Dr. Mohamed Khayyal (Egypt)
Dr. Enna will notify the above
organizations of these appointments.
Other Business:
The Executive Committee was
reminded that several members are celebrating milestone anniversaries, which
will be noted on the IUPHAR website and reported in the Pharmacology
International newsletter.
o
The Egyptian Society of Pharmacology and Experimental Therapeutics
is preparing to celebrate 50 years with a special meeting in Cairo.
o
The British Pharmacology Society is holding its 75th
anniversary celebration in Oxford during December 2006
o
The American Society of Pharmacology and Experimental Therapeutics
is preparing to celebrate its centenary in conjunction with the 2008
Experimental Biology Conference in San Diego.
Date and
Venue of Executive Committee Meeting in 2007:
The officers will hold their
next in-person meeting in conjunction with the November, 2006 NC-IUPHAR meeting
in Paris. The Executive Committee will next meet in conjunction with the spring
2007 NC-IUPHAR meeting in Paris. Dr. Enna will work with Dr. Spedding to
coordinate the agendas for these meetings.
The meeting
was adjourned at 3:25 p.m.
|
